ProShare Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $455K | Sell |
50,745
-3,413
| -6% | -$30.6K | ﹤0.01% | 1175 |
|
|
2025
Q1 | $406K | Sell |
54,158
-13,846
| -20% | -$104K | ﹤0.01% | 1209 |
|
|
2024
Q4 | $511K | Buy |
68,004
+16,732
| +33% | +$126K | ﹤0.01% | 1257 |
|
|
2024
Q3 | $390K | Buy |
51,272
+13,144
| +34% | +$99.9K | ﹤0.01% | 1294 |
|
|
2024
Q2 | $236K | Sell |
38,128
-10,375
| -21% | -$64.1K | ﹤0.01% | 1444 |
|
|
2024
Q1 | $246K | Buy |
48,503
+4,041
| +9% | +$20.5K | ﹤0.01% | 1544 |
|
|
2023
Q4 | $266K | Buy |
44,462
+7,450
| +20% | +$44.6K | ﹤0.01% | 1465 |
|
|
2023
Q3 | $262K | Buy |
37,012
+134
| +0.4% | +$949 | ﹤0.01% | 1283 |
|
|
2023
Q2 | $260K | Buy |
36,878
+1,981
| +6% | +$13.9K | ﹤0.01% | 1366 |
|
|
2023
Q1 | $291K | Sell |
34,897
-4,388
| -11% | -$36.6K | ﹤0.01% | 1230 |
|
|
2022
Q4 | $451K | Buy |
39,285
+3,202
| +9% | +$36.8K | ﹤0.01% | 1010 |
|
|
2022
Q3 | $455K | Buy |
36,083
+790
| +2% | +$9.96K | ﹤0.01% | 937 |
|
|
2022
Q2 | $374K | Sell |
35,293
-17,576
| -33% | -$186K | ﹤0.01% | 1087 |
|
|
2022
Q1 | $860K | Sell |
52,869
-11,704
| -18% | -$190K | ﹤0.01% | 977 |
|
|
2021
Q4 | $894K | Buy |
64,573
+3,575
| +6% | +$49.5K | ﹤0.01% | 1092 |
|
|
2021
Q3 | $877K | Sell |
60,998
-17,056
| -22% | -$245K | ﹤0.01% | 949 |
|
|
2021
Q2 | $1.23M | Buy |
78,054
+6,380
| +9% | +$101K | ﹤0.01% | 917 |
|
|
2021
Q1 | $729K | Buy |
71,674
+5,294
| +8% | +$53.8K | ﹤0.01% | 1187 |
|
|
2020
Q4 | $495K | Buy |
66,380
+16,273
| +32% | +$121K | ﹤0.01% | 1282 |
|
|
2020
Q3 | $172K | Buy |
50,107
+1,488
| +3% | +$5.11K | ﹤0.01% | 1445 |
|
|
2020
Q2 | $232K | Buy |
48,619
+18,414
| +61% | +$87.9K | ﹤0.01% | 1371 |
|
|
2020
Q1 | $60K | Sell |
30,205
-23,188
| -43% | -$46.1K | ﹤0.01% | 1109 |
|
|
2019
Q4 | $184K | Buy |
53,393
+10,952
| +26% | +$37.7K | ﹤0.01% | 1612 |
|
|
2019
Q3 | $122K | Sell |
42,441
-1,314
| -3% | -$3.78K | ﹤0.01% | 1525 |
|
|
2019
Q2 | $166K | Sell |
43,755
-5,356
| -11% | -$20.3K | ﹤0.01% | 1474 |
|
|
2019
Q1 | $400K | Buy |
49,111
+451
| +0.9% | +$3.67K | ﹤0.01% | 1121 |
|
|
2018
Q4 | $393K | Sell |
48,660
-9,293
| -16% | -$75.1K | ﹤0.01% | 1034 |
|
|
2018
Q3 | $442K | Buy |
57,953
+3,451
| +6% | +$26.3K | ﹤0.01% | 1164 |
|
|
2018
Q2 | $312K | Sell |
54,502
-3,533
| -6% | -$20.2K | ﹤0.01% | 1363 |
|
|
2018
Q1 | $277K | Sell |
58,035
-9,526
| -14% | -$45.5K | ﹤0.01% | 1365 |
|
|
2017
Q4 | $332K | Buy |
67,561
+16,754
| +33% | +$82.3K | ﹤0.01% | 1331 |
|
|
2017
Q3 | $266K | Buy |
50,807
+2,453
| +5% | +$12.8K | ﹤0.01% | 1183 |
|
|
2017
Q2 | $269K | Buy |
48,354
+427
| +0.9% | +$2.38K | ﹤0.01% | 1223 |
|
|
2017
Q1 | $403K | Sell |
47,927
-12,600
| -21% | -$106K | ﹤0.01% | 1097 |
|
|
2016
Q4 | $383K | Buy |
60,527
+6,790
| +13% | +$43K | ﹤0.01% | 1226 |
|
|
2016
Q3 | $237K | Sell |
53,737
-10,106
| -16% | -$44.6K | ﹤0.01% | 1262 |
|
|
2016
Q2 | $181K | Buy |
63,843
+876
| +1% | +$2.48K | ﹤0.01% | 1449 |
|
|
2016
Q1 | $178K | Sell |
62,967
-6,565
| -9% | -$18.6K | ﹤0.01% | 1446 |
|
|
2015
Q4 | $718K | Buy |
69,532
+6,755
| +11% | +$69.8K | 0.01% | 876 |
|
|
2015
Q3 | $716K | Sell |
62,777
-4,319
| -6% | -$49.3K | 0.01% | 788 |
|
|
2015
Q2 | $1M | Sell |
67,096
-4,345
| -6% | -$64.9K | 0.01% | 775 |
|
|
2015
Q1 | $645K | Buy |
71,441
+8,864
| +14% | +$80K | 0.01% | 1060 |
|
|
2014
Q4 | $761K | Sell |
62,577
-2,165
| -3% | -$26.3K | 0.01% | 990 |
|
|
2014
Q3 | $633K | Sell |
64,742
-11,866
| -15% | -$116K | 0.01% | 1265 |
|
|
2014
Q2 | $977K | Buy |
76,608
+31,373
| +69% | +$400K | 0.01% | 1175 |
|
|
2014
Q1 | $479K | Buy |
45,235
+19,349
| +75% | +$205K | 0.01% | 1901 |
|
|
2013
Q4 | $197K | Buy |
+25,886
| New | +$197K | ﹤0.01% | 1260 |
|
|
2013
Q3 | – | Sell |
-34,599
| Closed | -$54K | – | 2526 |
|
|
2013
Q2 | $54K | Buy |
+34,599
| New | +$54K | ﹤0.01% | 2351 |
|